Blog Band - Page 27 of 299

18

Shots: Accord BioPharma, a division of Intas Pharmaceuticals, has launched Imuldosa (ustekinumab-srlf), a biosimilar to Stelara The launch includes a $0 co-pay program for eligible pts with plaque psoriasis, psoriatic…

18

Aug 2025

NEWS

Eli Lilly Collaborates with Superluminal Medicines to Develop Small Molecule for Cardiometabolic Diseases and Obesity

Shots: Superluminal Medicines & Eli Lilly have partnered to develop small molecule therapeutics for undisclosed GPCR targets in cardiometabolic diseases & obesity, leveraging Superluminal’s drug discovery platform As per the…

18

Aug 2025

NEWS

Novo Nordisk Reports the US FDA’s Approval of Wegovy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Shots: The US FDA has approved a label extension for Wegovy to treat noncirrhotic MASH in adults with mod. to adv. liver fibrosis (F2 to F3 fibrosis) in combination with…

18

Aug 2025

NEWS

Precigen’s Papzimeos Receives the US FDA’s Full Approval for Recurrent Respiratory Papillomatosis

Shots: The US FDA has granted full approval to Papzimeos (zopapogene imadenovec-drba) for adults with recurrent respiratory papillomatosis (RRP), even though its BLA was originally submitted under the accelerated approval…

18

Aug 2025

EVENTS

Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 takes place in Vösendorf, Austria on 24-25 November. The 5th anniversary edition of AUTOMA+ gathers leading innovators and IT professionals to discuss…

18

Aug 2025

EVENTS

2025 BioPharma Deals: The Survival Series | Nov 24-25 | Munich, Germany

BioPharma Deals: The Survival Series brings together leaders from biotech, pharma, investment, CRO/CDMO, legal, and advisory sectors for a high-impact event focused on pragmatic deal-making, new financing models, early IPOs,…

14

Aug 2025

WEEKLY SNAPSHOT

PharmaShots Weekly Snapshots (Aug 11, 2025 – Aug 14, 2025) 

This week, PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, Animal Health, and Biosimilars. Check out our full report below:   Novartis Reports Topline P-III (NEPTUNUS-1…

14

Aug 2025

MAGAZINE

PharmaShots Magazine-August-2025 Edition

Aesthetic and beauty industry, underplayed by cosmeceuticals, shapes a soaring market worth $312.33B. Cosmeceuticals are known for their medical benefits beyond cosmetics and typically come in the forms of topical…

14

Aug 2025

NEWS

Sanofi’s Rilzabrutinib Secures the EMA’s Orphan Drug Designation to Treat IgG4-Related Disease

Shots: The EMA has granted ODD to rilzabrutinib for the treatment of IgG4-related disease (IgG4-RD) Rilzabrutinib (PO) is being evaluated in a P-II trial for IgG4-RD with glucocorticoids vs glucocorticoids…

14

Aug 2025

VIDEO

Accord BioPharma launches Imuldosa (Biosimilar, Stelara) PFS at the lowest WAC

Eli Lilly Collaborates with Superluminal Medicines to Develop Small Molecule for Cardiometabolic Diseases and Obesity

Novo Nordisk Reports the US FDA’s Approval of Wegovy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Precigen’s Papzimeos Receives the US FDA’s Full Approval for Recurrent Respiratory Papillomatosis

Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025

2025 BioPharma Deals: The Survival Series | Nov 24-25 | Munich, Germany

PharmaShots Weekly Snapshots (Aug 11, 2025 – Aug 14, 2025)

PharmaShots Magazine-August-2025 Edition

LIFE SCIENCES | DAILY NEWS | AUG 14, 2025 | PHARMASHOTS

Contact US

OUR INFORMATION

FOLLOW US